368 related articles for article (PubMed ID: 31070303)
1. Comprehensive characterization of cancer-testis genes in testicular germ cell tumor.
Chang Y; Wang X; Xu Y; Yang L; Qian Q; Ju S; Chen Y; Chen S; Qin N; Ma Z; Dai J; Ma H; Jin G; Zhang E; Wang C; Hu Z
Cancer Med; 2019 Jul; 8(7):3511-3519. PubMed ID: 31070303
[TBL] [Abstract][Full Text] [Related]
2. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA RFPL3S Functions as a Biomarker of Prognostic and Immunotherapeutic Prediction in Testicular Germ Cell Tumor.
Guo J; Wang S; Jiang Z; Tang L; Liu Z; Cao J; Hu Z; Chen X; Luo Y; Bo H
Front Immunol; 2022; 13():859730. PubMed ID: 35669771
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 2 (TLR2) is a candidate prognostic factor in testicular germ cell tumors as well as an indicator of immune function in the tumor microenvironment.
Wu H; Zhang Z; Xiao XY; Zhang ZY; Gao SL; Lu C; Zuo L; Zhang LF
Bioengineered; 2021 Dec; 12(1):1939-1951. PubMed ID: 34002664
[TBL] [Abstract][Full Text] [Related]
5. Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.
Boublikova L; Bakardjieva-Mihaylova V; Skvarova Kramarzova K; Kuzilkova D; Dobiasova A; Fiser K; Stuchly J; Kotrova M; Buchler T; Dusek P; Grega M; Rosova B; Vernerova Z; Klezl P; Pesl M; Zachoval R; Krolupper M; Kubecova M; Stahalova V; Abrahamova J; Babjuk M; Kodet R; Trka J
Cancer Lett; 2016 Jul; 376(2):367-76. PubMed ID: 27085458
[TBL] [Abstract][Full Text] [Related]
6. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
Ahmad F; Surve P; Natarajan S; Patil A; Pol S; Patole K; Das BR
Cancer Genet; 2020 Feb; 241():42-50. PubMed ID: 31653608
[TBL] [Abstract][Full Text] [Related]
7. Profiling of the small RNA populations in human testicular germ cell tumors shows global loss of piRNAs.
Rounge TB; Furu K; Skotheim RI; Haugen TB; Grotmol T; Enerly E
Mol Cancer; 2015 Aug; 14():153. PubMed ID: 26265322
[TBL] [Abstract][Full Text] [Related]
8. miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update.
De Martino M; Chieffi P; Esposito F
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573132
[TBL] [Abstract][Full Text] [Related]
9. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling.
Cools M; Wolffenbuttel KP; Hersmus R; Mendonca BB; Kaprová J; Drop SLS; Stoop H; Gillis AJM; Oosterhuis JW; Costa EMF; Domenice S; Nishi MY; Wunsch L; Quigley CA; T'Sjoen G; Looijenga LHJ
Hum Reprod; 2017 Dec; 32(12):2561-2573. PubMed ID: 29121256
[TBL] [Abstract][Full Text] [Related]
10. Hypomethylation-driven AKT Serine/Threonine Kinase 3 promotes testicular germ cell tumors proliferation and negatively correlates to immune infiltration.
Luo Y; Zhou Q; Zhu F; Fan L; Bo H; Wang X
Bioengineered; 2021 Dec; 12(2):11288-11302. PubMed ID: 34882061
[TBL] [Abstract][Full Text] [Related]
11. Functions of genes related to testicular germ cell tumour development.
Das MK; Kleppa L; Haugen TB
Andrology; 2019 Jul; 7(4):527-535. PubMed ID: 31310060
[TBL] [Abstract][Full Text] [Related]
12.
Liu Z; Fang B; Cao J; Zhou Q; Zhu F; Fan L; Xue L; Huang C; Bo H
Bioengineered; 2022 May; 13(5):12141-12155. PubMed ID: 35575252
[TBL] [Abstract][Full Text] [Related]
13. Expression of splicing variants of the inhibitor of apoptosis livin in testicular germ cell tumors.
Kempkensteffen C; Hinz S; Krause H; Jager T; Köllermann J; Weikert S; Christoph F; Schostak M; Miller K; Schrader M
Tumour Biol; 2008; 29(2):76-82. PubMed ID: 18515985
[TBL] [Abstract][Full Text] [Related]
14. [Expression levels of the IAP antagonists XAF1, Smac/DIABLO and HtrA2 in testicular germ cell tumours].
Kempkensteffen C; Hinz S; Jäger T; Weikert S; Krause H; Schostak M; Christoph F; Strenziok R; Miller K; Schrader M
Aktuelle Urol; 2008 Nov; 39(6):436-41. PubMed ID: 18979398
[TBL] [Abstract][Full Text] [Related]
15. Testicular Germ Cell Tumor Tissue Biomarker Analysis: A Comparison of Human Protein Atlas and Individual Testicular Germ Cell Tumor Component Immunohistochemistry.
Krasic J; Skara Abramovic L; Himelreich Peric M; Vanjorek V; Gangur M; Zovko D; Malnar M; Masic S; Demirovic A; Juric B; Ulamec M; Coric M; Jezek D; Kulis T; Sincic N
Cells; 2023 Jul; 12(14):. PubMed ID: 37508506
[TBL] [Abstract][Full Text] [Related]
16. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
[TBL] [Abstract][Full Text] [Related]
17. Identification of mRNA Prognostic Markers for TGCT by Integration of Co-Expression and CeRNA Network.
Zhu F; Liu Z; Zhou Q; Fan J; Zhou D; Xing L; Bo H; Tang L; Fan L
Front Endocrinol (Lausanne); 2021; 12():743155. PubMed ID: 34621245
[TBL] [Abstract][Full Text] [Related]
18. Meta-Analysis of Gene Expressions in Testicular Germ Cell Tumor Histologies.
von Eyben FE; Parraga-Alava J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599785
[TBL] [Abstract][Full Text] [Related]
19. The genomic landscape of testicular germ cell tumours: from susceptibility to treatment.
Litchfield K; Levy M; Huddart RA; Shipley J; Turnbull C
Nat Rev Urol; 2016 Jul; 13(7):409-19. PubMed ID: 27296647
[TBL] [Abstract][Full Text] [Related]
20. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors.
Wang Y; Ji C; Liu J; Wang Y; Song N; Cao P
Int Immunopharmacol; 2020 Sep; 86():106710. PubMed ID: 32652500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
